Vaccines
- Name
- Vaccines
- Accession Number
- DBCAT002013
- Description
Suspensions of killed or attenuated microorganisms (bacteria, viruses, fungi, protozoa), antigenic proteins, synthetic constructs, or other bio-molecular derivatives, administered for the prevention, amelioration, or treatment of infectious and other diseases.
- ATC Classification
- Drugs
Drug Drug Description Varicella zoster vaccine (live/attenuated) Zostavax vaccine is indicated for the prevention of herpes zoster (shingles) in immunocompetent adults aged 50 years and older. Varivax vaccine is indicated for active immunization for the prevention of... Yellow fever vaccine Yellow Fever Vaccine is indicated for active immunization for the prevention of yellow fever in persons 9 months of age and older in the following categories: Persons Living in or... Clostridium tetani toxoid antigen (formaldehyde inactivated) Clostridium tetani toxoid antigen (formaldehyde inactivated) is a vaccine for intramuscular injection. It is used for active immunization of children 7 years of age or older, and adults, for prevention... Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) Not Annotated Rotavirus vaccine Rotarix is indicated for prevention of rotavirus gastroenteritis caused by G1, G3, G4, and G9 types in infants aged 6-24 weeks [FDA Label]. Rotateq is indicated for the prevention of... G17DT Immunogen Intended for the treatment of various forms of cancer. INGN 225 Investigated for use/treatment in breast cancer, head and neck cancer, and lung cancer. Rindopepimut Investigated for use/treatment in brain cancer. SRP 299 Investigated for use/treatment in asthma, atopic dermatitis, and pediatric atopic dermatitis indications. GI-5005 Investigated for use/treatment in hepatitis (viral, C). TG4010 Investigated for use/treatment in breast cancer, renal cell carcinoma, prostate cancer, and lung cancer. Rabies virus inactivated antigen, A Rabies virus inactivated antigen, A is an inactivated virus vacine for the intramuscular injection. It is an active immunization against rabies that can be administered pre- or post-exposure to the... Tecemotide Tecemotide has been used in trials studying the treatment of Prostate Cancer and Carcinoma, Non-Small-Cell Lung. BCG vaccine A vaccine indicated in the prevention of tuberculosis and the treatment of non-invasive urothelial bladder cancer. Typhoid vaccine A vaccine used to prevent typhoid. Rubella virus vaccine A vaccine used to prevent Rubella. Anthrax immune globulin human An immunizing agent used for the treatment of inhalational anthrax in adult and pediatric patients in combination with antibacterial agents. Bacillus calmette-guerin substrain tice live antigen A live attenuated vaccine against Mycobacterium bovis. Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) Not Annotated Typhoid Vi polysaccharide vaccine Typhoid Vi polysaccharide vaccine is a vaccine that is administered intramuscularly. It is an active immunization for the prevention of typhoid fever caused by S typhi and is approved for... Bacillus calmette-guerin substrain connaught live antigen Indicated for intravesical use in the treatment and prophylaxis of carcinoma in situ (CIS) of the urinary bladder and for the prophylaxis of primary or recurrent stage Ta and/or T1... Hepatitis A Vaccine An inactivated vaccine against infection with the Hepatitis A virus. Typhoid Vaccine Live Salmonella typhi Ty21a live antigen is a live attenuated vaccine for oral administration only. It contains the attenuated strain Salmonella typhi Ty21a. The vaccine prevents the development of typhoid fever,... Rabies immune globulin, human A solution of antibodies used to prevent rabies after an exposure. Hepatitis B Vaccine (Recombinant) A solution of Hepatitis B surface antigen used to immunize patients against Hepatitis B. Anthrax vaccine A vaccine indicated for the pre- and post-exposure prophylaxis treatment of diseases caused by exposure to Bacillus anthracis Bacillus calmette-guerin substrain danish 1331 live antigen BCG SSI has been used in trials studying Tuberculosis. Vibrio cholerae CVD 103-HgR strain live antigen A live, attenuated vaccine indicated for active immunization against disease caused by Vibrio cholerae serogroup O1. Human adenovirus e serotype 4 strain cl-68578 antigen Human adenovirus e serotype 4 strain cl-68578 antigen is a vaccine. Adenovirus type 7 vaccine live Not Annotated Smallpox (Vaccinia) Vaccine, Live The live antigen of the New York City Board of Health strain of Vaccinia is indicated (within the ACAM2000 formulation) for active immunization against smallpox disease in patients determined to... Rabies virus inactivated antigen, B Inactivated rabies virus antigen B is indicated for pre- and post-exposure prophylaxis against rabies. PEV3A Investigated for use/treatment in malaria. Vitespen Investigated for use/treatment in kidney cancer, melanoma, renal cell carcinoma, lymphoma (unspecified), colorectal cancer, and brain cancer. Influenza A virus A/Brisbane/59/2007(H1N1) antigen (propiolactone inactivated) A seasonally-specific component of the influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that protects against infection from the influenza viruses. Vaccines provide protection... Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen Indicated for active immunization in pediatric patients 15 months through 4 years of age as a booster dose for the prevention of invasive disease caused by Haemophilus influenzae type b. Influenza A virus A/Brisbane/59/2007(H1N1) hemagglutinin antigen (propiolactone inactivated) A seasonally-specific component of the influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that protects against infection from the influenza viruses. Vaccines provide protection... Influenza A virus A/California/7/2009 X-181 (H1N1) hemagglutinin antigen (propiolactone inactivated) A seasonally-specific component of the influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that protects against infection from the influenza viruses. Vaccines provide protection... Influenza A virus A/Victoria/210/2009 X-187 (H3N2) hemagglutinin antigen (formaldehyde inactivated) A seasonally-specific component of the influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that protects against infection from the influenza viruses. Vaccines provide protection... Influenza A virus A/Victoria/210/2009 X-187 (H3N2) antigen (formaldehyde inactivated) A seasonally-specific component of the influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that protects against infection from the influenza viruses. Vaccines provide protection... Influenza A virus A/California/7/2009 X-181 (H1N1) antigen (propiolactone inactivated) A seasonally-specific component of the influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that protects against infection from the influenza viruses. Vaccines provide protection... Influenza A virus A/Uruguay/716/2007(H3N2) antigen (propiolactone inactivated) A seasonally-specific component of the influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that protects against infection from the influenza viruses. Vaccines provide protection... Influenza A virus A/California/7/2009 (H1N1) live (attenuated) antigen A seasonally-specific component of the influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that protects against infection from the influenza viruses. Vaccines provide protection... Influenza A virus A/Perth/16/2009 (H3N2) live (attenuated) antigen A seasonally-specific component of the influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that protects against infection from the influenza viruses. Vaccines provide protection... Influenza B virus B/Brisbane/60/2008 antigen (formaldehyde inactivated) A seasonally-specific component of the influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that protects against infection from the influenza viruses. Vaccines provide protection... Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (propiolactone inactivated) A seasonally-specific component of the influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that protects against infection from the influenza viruses. Vaccines provide protection... Influenza B virus B/Brisbane/60/2008 antigen (propiolactone inactivated) A seasonally-specific component of the influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that protects against infection from the influenza viruses. Vaccines provide protection... Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (formaldehyde inactivated) An influenza antigen used in seasonal influenza vaccines. Pertussis vaccine Pertussis vaccine is under investigation in clinical trial NCT01698346 (Pertussis (Tdap) Vaccination in Pregnancy). Yersinia pestis 195/p antigen (formaldehyde inactivated) Yersinia pestis 195/p antigen (formaldehyde inactivated) is under investigation in clinical trial NCT02596308 (Immunogenicity and Safety of Subunit Plague Vaccine). Varicella zoster vaccine (recombinant) Varicella zoster vaccine is indicated for the prevention of herpes zoster (HZ) (shingles) in adults aged 50 years and older and in adults aged 18 years and older who are... Modified vaccinia ankara A live, non-replicating orthopoxvirus vaccine used to prevent smallpox, monkeypox, and other diseases caused by vaccinia virus. Ebola Zaire vaccine (live, attenuated) A vaccine used in the prophylaxis of Ebola virus disease caused by the species of Zaire ebolaviruses. Measles virus vaccine live attenuated A vaccine used to prevent Measles. Moderna COVID-19 Vaccine An mRNA vaccine for the prevention of COVID-19 caused by the SARS-CoV-2 virus. Influenza A virus A/Hong Kong/2671/2019 IVR-208 (H3N2) antigen (formaldehyde inactivated) A seasonally-specific component of the influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that protects against infection from the influenza viruses. Vaccines provide protection... Influenza A virus A/Victoria/2570/2019 IVR-215 (H1N1) antigen (formaldehyde inactivated) A seasonally-specific component of the influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that protects against infection from the influenza viruses. Vaccines provide protection... Influenza B virus Yamagata lineage haemagglutinin, recombinant Not Annotated Influenza B virus Victoria lineage haemagglutinin, recombinant Not Annotated Influenza A virus subtype H1N1 haemagglutinin, recombinant Not Annotated Influenza A virus subtype H3N2 haemagglutinin, recombinant Not Annotated Influenza A virus A/Vietnam/1194/2004 (H5N1) antigen (formaldehyde inactivated) Not Annotated Bacillus calmette-guerin substrain russian BCG-I live antigen An intravesically-administered live BCG vaccine used to treat papillary urothelial cell carcinoma of the bladder. Janssen COVID-19 Vaccine An adenovirus-based vaccine used for active immunization against COVID-19 caused by SARS-CoV-2 infection. Influenza A virus A/Tasmania/503/2020 IVR-221 (H3N2) antigen (formaldehyde inactivated) A seasonally-specific component of the influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that protects against infection from the influenza viruses. Vaccines provide protection... Influenza B virus B/Phuket/3073/2013 antigen (formaldehyde inactivated) A seasonally-specific component of the influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that protects against infection from the influenza viruses. Vaccines provide protection... Influenza A virus A/Wisconsin/588/2019 (H1N1) recombinant hemagglutinin antigen A seasonally-specific component of the influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that protects against infection from the influenza viruses. Vaccines provide protection... Influenza B virus B/Washington/02/2019 recombinant hemagglutinin antigen A seasonally-specific component of the influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that protects against infection from the influenza viruses. Vaccines provide protection... Influenza A virus A/Tasmania/503/2020 (H3N2) live (attenuated) antigen A seasonally-specific component of the influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that protects against infection from the influenza viruses. Vaccines provide protection... Influenza A virus A/Victoria/1/2020 (H1N1) live (attenuated) antigen Not Annotated Tick-borne encephalitis vaccine (whole virus, inactivated) A whole inactivated viral vaccine against meningoencephalitis caused by the tick-borne encephalitis virus. Tozinameran An mRNA vaccine for the prevention of COVID-19 caused by the SARS-CoV-2 virus. Influenza A virus A/Victoria/2570/2019 IVR-215 (H1N1) antigen (UV, formaldehyde inactivated) A seasonally-specific component of the influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that protects against infection from the influenza viruses. Vaccines provide protection... Influenza A virus A/Tasmania/503/2020 IVR-221 (H3N2) antigen (UV, formaldehyde inactivated) A seasonally-specific component of the influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that protects against infection from the influenza viruses. Vaccines provide protection... Influenza A virus A/Victoria/2570/2019 IVR-215 (H1N1) antigen (propiolactone inactivated) A seasonally-specific component of the influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that protects against infection from the influenza viruses. Vaccines provide protection... Influenza A virus A/Cambodia/e0826360/2020 IVR-224 (H3N2) antigen (propiolactone inactivated) A seasonally-specific component of the influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that protects against infection from the influenza viruses. Vaccines provide protection... Influenza A virus A/Cambodia/e0826360/2020 IVR-224 (H3N2) antigen (formaldehyde inactivated) A seasonally-specific component of the influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that protects against infection from the influenza viruses. Vaccines provide protection... Influenza A virus A/Tasmania/503/2020 (H3N2) antigen (MDCK cell derived, propiolactone inactivated) In combination with other influenza virus subtypes A and types B strains, this Influenza A viral strain is used for active immunization of adults and children aged 6 months or... Influenza A virus A/Washington/19/2020 (H1N1) antigen (MDCK cell derived, propiolactone inactivated) In combination with other influenza virus subtypes A and types B strains, this Influenza A viral strain is used for active immunization of adults and children aged 6 months or... Influenza A virus A/Tasmania/503/2020 (H3N2) recombinant hemagglutinin antigen Not Annotated Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) is a vaccine that is used in the prophylaxis of Pertussis (whooping cough), which is caused by a small Gram-negative coccobacillus that infects... Mumps virus strain B level jeryl lynn live antigen A vaccine used to prevent Mumps. Nuvaxovid A recombinant spike (S) protein vaccine for the prevention of COVID-19 caused by SARS-CoV-2. Dengue tetravalent vaccine, live Not Annotated AstraZeneca COVID-19 Vaccine A two-dose replication-deficient adenovirus vector vaccine used to prevent COVID-19 caused by SARS-CoV-2. INO-4800 INO-4800 is a DNA vaccine containing the full sequence for the SARS-CoV-2 Spike (S) protein in development for immunization against COVID-19. Early in vitro studies using HEK-293T cells demonstrated that... BNT162b1 SARS-CoV-2 Vaccine BNT162b1 is one of four advanced mRNA-based vaccines being developed through "Project Lightspeed," a joint program between Pfizer and BioNTech.[L15002, L15007] BNT162b1 is a nucleoside modified mRNA (modRNA) vaccine encoding... VPM1002 The bacille Calmette-Guérin (BCG) vaccine protects against severe extrapulmonary forms of tuberculosis (TB) but does not adequately protect against pulmonary TB -- the most prevalent form of TB. This recombinant... BBIBP-CorV BBIBP-CorV vaccine contains a SARS-CoV-2 strain inactivated inside Vero Cells. Investigation shows this vaccine induces neutralizing antibodies in several mammalian species while also showing protective efficacy with SARS-CoV-2 challenge in... IMM-101 IMM-101 is a heat-inactivated immune-activating mycobacterial product. It has shown to be safe and well tolerated to complement conventional cancer therapy for patients with melanoma and pancreatic ductal adenocarcinoma[A220013,A220018,A220023]. Studies... Bizalimogene ralaplasmid Bizalimogene ralaplasmid is under investigation in clinical trial NCT03499795 (VGX-3100 Delivered Intramuscularly (IM) Followed by Electroporation (EP) for the Treatment of HPV-16 And/or HPV-18 Related Anal or Anal/peri-anal, High Grade... Pidacmeran Pidacmeran is under investigation in clinical trial NCT04380701 (A Trial Investigating the Safety and Effects of Four BNT162 Vaccines Against COVID-2019 in Healthy Adults). BNT-162A1 BNT-162A1 is under investigation in clinical trial NCT04380701 (A Trial Investigating the Safety and Effects of Four BNT162 Vaccines Against COVID-2019 in Healthy Adults). VidPrevtyn Beta A recombinant, adjuvanted DNA vaccine given as a booster dose to prevent COVID-19. EpiVacCorona EpiVacCorona Vaccine, developed by the Vektor State Research Center of Virology and Biotechnology in Russia, is based on peptide-antigens that facilitate immunity to the SARS-CoV-2 virus . It is currently... Plant-based virus-like particles, recombinant, adjuvanted COVID-19 vaccine A vaccine comprising purified SARS-CoV-2 spike protein expressed in plant-based virus-like particles for the prevention of COVID-19 in adult patients. Influenza A virus A/Norway/16606/2021 (H3N2) live (attenuated) antigen A component of a live attenuated influenza vaccine. Influenza B virus B/Austria/1359417/2021 live (attenuated) antigen A component of a live attenuated influenza vaccine. Influenza A virus A/Darwin/6/2021 IVR-227 (H3N2) antigen (formaldehyde inactivated) A component of an inactivated influenza vaccine. Influenza B virus B/Austria/1359417/2021 BVR-26 hemagglutinin antigen (formaldehyde inactivated) A component of an inactivated influenza vaccine. Influenza B virus B/Singapore/WUH4618/2021 antigen (MDCK cell derived, propiolactone inactivated) A component of an inactivated influenza vaccine. Influenza A virus A/Darwin/11/2021 (H3N2) antigen (MDCK cell derived, propiolactone inactivated) A component of an inactivated influenza vaccine Influenza A virus A/Delaware/55/2019 CVR-45 (H1N1) antigen (MDCK cell derived, propiolactone inactivated) A component of an inactivated influenza vaccine. Influenza A virus A/Darwin/9/2021 SAN-010 (H3N2) antigen (formaldehyde inactivated) A component of an inactivated influenza vaccine. Influenza B virus B/Michigan/01/2021 antigen (formaldehyde inactivated) A component of an inactivated influenza vaccine. Influenza A virus A/Darwin/6/2021 IVR-227 (H3N2) antigen (propiolactone inactivated) A component of an inactivated influenza vaccine. Influenza B virus B/Austria/1359417/2021 BVR-26 antigen (propiolactone inactivated) A component of an inactivated influenza vaccine. Influenza A virus A/Darwin/6/2021 (H3N2) recombinant hemagglutinin antigen A component of a recombinant influenza vaccine comprising a recombinant influenza hemagglutinin antigen. Influenza B virus B/Austria/1359417/2021 recombinant hemagglutinin antigen A component of a recombinant influenza vaccine comprising a recombinant influenza hemagglutinin antigen. Influenza A virus A/Darwin/9/2021 IVR-228 (H3N2) antigen (UV, formaldehyde inactivated) A component of an inactivated influenza vaccine. Influenza B virus B/Austria/1359417/2021 BVR-26 antigen (UV, formaldehyde inactivated) A component of an inactivated influenza vaccine. Meningococcal (groups A, C, Y and W-135) oligosaccharide diphtheria CRM197 conjugate vaccine A conjugate vaccine used to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y, and W-135. Davesomeran An mRNA vaccine in combination with the Moderna COVID-19 vaccine to prevent infection from the Omicron variant of the SARS-CoV-2 virus in people 6 years old or older. Famtozinameran A component of a bivalent COVID-19 mRNA vaccine encoding the viral spike protein of Omicron variant lineages BA.4 and BA.5. Algenpantucel-L Not Annotated Leuvectin Leuvectin (formerly known as VCL-1102) is a component of gene therapy along with cationic lipid 1,2-dimyristyloxypropyl-3-dimethyl-hydroxyethyl ammonium bromide/dioleyl-phosphatidyl-ethanolamine (DMRIE/DOPE). Onamelatucel-L Not Annotated Gemogenovatucel-T Gemogenovatucel-T is a bi-shRNA furin/Granulocyte Macrophage Colony Stimulating Factor (GMCSF) Augmented autologous tumour cell vaccine. Furin is a convertase involved in the activation of TGFβ-1 and TGFβ-2. Gemogenovatucel-T is being... GI-6207 Not Annotated Imelasomeran A component of a bivalent COVID-19 mRNA vaccine encoding the viral spike protein of Omicron variant lineage BA.1. Riltozinameran A component of a bivalent COVID-19 mRNA vaccine encoding the viral spike protein of Omicron variant lineage BA.1. SCB-2019 SCB-2019 is a recombinant trimeric S protein subunit vaccine candidate being investigated against COVID-19. This vaccine candidate resembles the native trimeric viral spike and is produced through mammalian cell-culture. The... CoronaVac CoronaVac, previously known as PiCoVacc, is a SARS-CoV-2 purified, inactivated, and adsorbed vaccine candidate developed by SinoVac Biotech Corporation . It was developed by propagating the SARS-CoV-2 CN2 strain inside... CVnCoV Vaccine The CVnCov Vaccine (or CV07050101) is in development by CureVac AG. The vaccine uses mRNA technology to create a protein associated with SARS-CoV2, and upon administration and replication, to initiate... BBV152 BBV152 is a vaccine candidate created by the Indian Council of Medical Research (ICMR). The candidate, a whole virion inactivated SARS-CoV-2 vaccine, was developed from a well-known SARS-CoV-2 strain and... Rocakinogene sifuplasmid Rocakinogene sifuplasmid is under investigation in clinical trial NCT03491683 (INO-5401 and INO-9012 Delivered by Electroporation (EP) in Combination With Cemiplimab (REGN2810) in Newly-diagnosed Glioblastoma (GBM)). CoVac-1 Sponsored by the University Hospital Tuebingen in Germany, CoVac-1 is a multi-peptide COVID-19 vaccine candidate created from HLA class I and HLA-DR T-cell epitopes of the S-protein . It is... UB-612 The UB-612 COVID-19 vaccine was developed by United Biomedical Inc Asia in Taipei as the first COVID-19 “multi-tope” protein-peptide vaccine made up of eight rationally designed components . The vaccine... Tubimod Not Available Respiratory syncytial virus vaccine, adjuvanted An adjuvanted respiratory syncytial virus vaccine in older adults. Influenza A Virus A/Sydney/5/2021 SAN-013 (H1N1) antigen (formaldehyde inactivated) A component of an inactivated influenza vaccine. Remune Not Available Mycobacterium w. Vaccine The Mycobacterium w (M.w) vaccine is a heat-killed suspension derived from a non-pathogenic mycobacterium: mycobacterium indicus pranii. As an immunotherapy, M.w is used against leprosy; the compound also shares antigens... Influenza A Virus A/Victoria/4897/2022 IVR-238 (H1N1) antigen (formaldehyde inactivated) A component of an inactivated influenza vaccine. Influenza A virus A/West Virginia/30/2022 (H1N1) Recombinant Hemagglutinin Antigen A component of a recombinant influenza vaccine comprising a recombinant influenza hemagglutinin antigen. Influenza A virus A/Georgia/12/2022 CVR-167 (H1N1) Antigen (MDCK cell derived, propiolactone inactivated) A component of an inactivated influenza vaccine. Influenza A virus A/Victoria/4897/2022 IVR-238 (H1N1) Antigen (propiolactone inactivated) A component of an inactivated influenza vaccine. Influenza A virus A/Victoria/4897/2022 IVR-238 (H1N1) Antigen (UV, formaldehyde inactivated) A component of an inactivated influenza vaccine. Influenza A virus A/Norway/31694/2022 (H1N1) live (attenuated) antigen A component of a live attenuated influenza vaccine. Chikungunya vaccine (live, attenuated) A live, attenuated vaccine used for the prevention of disease caused by chikungunya virus. Andusomeran An mRNA vaccine for the prevention of COVID-19 caused by the SARS-CoV-2 virus, including the XBB.1.5 subvariant. SARS-CoV-2 virus recombinant spike (S) protein receptor binding domain (RBD) fusion heterodimer (B.1.351-B.1.1.7 strains) A recombinant non-mRNA COVID-19 vaccine. Recombinant stabilized RSV A prefusion F antigen One component of a bivalent recombinant RSV vaccine. Recombinant stabilized RSV B prefusion F antigen One component of a bivalent recombinant RSV vaccine. - Drugs & Drug Targets